These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29577987)

  • 41. Mast Cell Burden in a Patient With Cutaneous Disease.
    Awosika O; Eleryan M; Rengifo-Pardo M; Ehrlich A
    J Drugs Dermatol; 2017 Dec; 16(12):1285-1287. PubMed ID: 29240865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxidative stress markers are increased in patients with mastocytosis.
    Gangemi S; Minciullo PL; Magliacane D; Saitta S; Loffredo S; Saija A; Cristani M; Marone G; Triggiani M
    Allergy; 2015 Apr; 70(4):436-42. PubMed ID: 25630934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
    Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
    J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonclonal Mast Cell Activation Syndrome: A Growing Body of Evidence.
    Hamilton MJ
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):469-481. PubMed ID: 30007464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Postural Tachycardia Syndrome and Ehlers-Danlos Syndrome with Mast Cell Activation Disorders.
    Bonamichi-Santos R; Yoshimi-Kanamori K; Giavina-Bianchi P; Aun MV
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):497-504. PubMed ID: 30007466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology, prognosis, and risk factors in mastocytosis.
    Brockow K
    Immunol Allergy Clin North Am; 2014 May; 34(2):283-95. PubMed ID: 24745674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. INTERACTIVE MEDICAL CASE. A Stinging Sensation.
    Lee-Sarwar K; Vaidya A; Shi M; Akin C
    N Engl J Med; 2015 Jun; 372(26):e35. PubMed ID: 26107069
    [No Abstract]   [Full Text] [Related]  

  • 48. Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.
    Steinke JW; Payne SC; Borish L
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):719-734. PubMed ID: 27712766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH; Weiler CR
    Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis.
    Butterfield JH; Ravi A; Pongdee T
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):397-410. PubMed ID: 30007459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemokines as allergic mediators--relationship to histamine-releasing factors.
    Kaplan AP; Kuna P; Reddigari SR
    Allergy; 1994 Aug; 49(7):495-501. PubMed ID: 7529967
    [No Abstract]   [Full Text] [Related]  

  • 52. [Mastocytosis: when should it be considered?].
    Comte-Perret S; Bart PA; Spertini F; Leimgruber A
    Rev Med Suisse; 2009 Apr; 5(199):837-42. PubMed ID: 19441750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.
    Schwartz LB; Metcalfe DD; Miller JS; Earl H; Sullivan T
    N Engl J Med; 1987 Jun; 316(26):1622-6. PubMed ID: 3295549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis.
    Gülen T; Möller Westerberg C; Lyberg K; Ekoff M; Kolmert J; Bood J; Öhd J; James A; Dahlén SE; Nilsson G; Dahlén B
    Clin Exp Allergy; 2017 Jul; 47(7):909-917. PubMed ID: 28258965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathology of extramedullary mastocytosis.
    Doyle LA; Hornick JL
    Immunol Allergy Clin North Am; 2014 May; 34(2):323-39. PubMed ID: 24745677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mast cell and eosinophil activation during early phase of grass pollen-induced ocular allergic reaction.
    Jedrzejczak-Czechowicz M; Lewandowska-Polak A; Jarzebska M; Kowalski ML
    Allergy Asthma Proc; 2011; 32(1):43-8. PubMed ID: 21262097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The potential of active metabolites of antihistamines in the management of allergic disease.
    Abdelaziz MM; Khair OA; Devalia JL
    Allergy; 2000 May; 55(5):425-34. PubMed ID: 10843422
    [No Abstract]   [Full Text] [Related]  

  • 58. Mast cell activation syndromes.
    Lee MJ; Akin C
    Ann Allergy Asthma Immunol; 2013 Jul; 111(1):5-8. PubMed ID: 23806452
    [No Abstract]   [Full Text] [Related]  

  • 59. Pimecrolimus induces apoptosis of mast cells in a murine model of cutaneous mastocytosis.
    Ma Z; Tovar JP; Kwong KY; Paek D
    Int Arch Allergy Immunol; 2010; 153(4):413-8. PubMed ID: 20559008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How good are mast cell mediators?
    Weiler CR
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):410-411. PubMed ID: 34303837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.